Barclays
SLRN

Barclays’s ACELYRIN SLRN Stock Holding History

Barclays’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-400
Closed -$2.7K – 5263
2024
Q1 		$2.7K Buy
+400
New +$3.04K ﹤0.01% 4900

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's SLRN Position: Q2 2025 in Review

Barclays sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 82,871 shares — an estimated $205K sold.

Barclays first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $5.35M in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Barclays reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Barclays sold 82,871 ACELYRIN shares in Q2 2025, an estimated $205K.
  • Barclays first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
  • Barclays's ACELYRIN position peaked at $5.35M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.